Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
|
|
Invivyd, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/27/2023 |
4
| Cotter Sara (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.39, valued at
$139k
|
|
| 05/25/2023 |
4
| MCGUIRE TERRANCE (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 05/25/2023 |
4
| Heyman Tomas J. (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 05/25/2023 |
4
| WYZGA MICHAEL S (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 05/25/2023 |
4
| Lindenboom Christine (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 29,589 options to buy
@ $1.7, valued at
$50.3k
|
|
| 05/25/2023 |
4
| MEANWELL CLIVE (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 05/25/2023 |
4
| Berry Tamsin (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 05/25/2023 |
4
| Elia Marc (Director) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 50,000 options to buy
@ $1.7, valued at
$85k
|
|
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2022 |
4
| Schmidt Peter (Chief Medical Officer) has filed a Form 4 on Invivyd, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.95, valued at
$585k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2022 |
4
| Hering David (CEO) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Bought 8,000 shares
@ $4.52, valued at
$36.2k
|
|
| 08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2022 |
4
| Hering David (CEO) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Granted 2,000,000 options to buy
@ $3.37, valued at
$6.7M
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Berry Tamsin (Director) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $3.09, valued at
$463.5k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2022 |
4
| Adimab, LLC (10% Owner) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Disposed of 1,158,089 shares
@ $0 |
|
| 03/30/2022 |
4
| Royan Ajay (10% Owner) has filed a Form 4 on Adagio Therapeutics, Inc. |
| 03/30/2022 |
4
| MITHRIL II LP (10% Owner) has filed a Form 4 on Adagio Therapeutics, Inc. |
| 03/30/2022 |
4
| MCGUIRE TERRANCE (Director) has filed a Form 4 on Adagio Therapeutics, Inc. |
| 02/01/2022 |
4
| Hershberger Elham (Chief Development Officer) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $6.78, valued at
$1.2M
|
|
| 02/01/2022 |
4
| Hering David (COO) has filed a Form 4 on Adagio Therapeutics, Inc.|
Txns:
| Granted 475,000 options to buy
@ $6.78, valued at
$3.2M
|
|
|
|
|